Fundraising Fox
/Companies
Sign in

InpharmD

YC W21

Atlanta, US · Founded 2018 · 16 employees · 13 known investors

Find your way into InpharmD

Sign up to see every warm intro you have to InpharmD

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the InpharmD team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

InPharmD is a medical literature research platform that analyzes published studies to answer clinical pharmacology questions, specifically focused on adverse drug reactions and medication safety.

AI & Machine LearningDigital HealthHealthtechArtificial IntelligenceB2BTelemedicineUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W21)

InpharmD was founded in 2018 by Ashish Advani and Tulasee Rao Chintha.

AAAshish Advani
Ashish AdvaniFounderAshish Advani holds a PharmD from the University of Georgia and studied at Oxford University. He has spent a decade as a clinical pharmacist specializing in drug information at Atlanta Medical Center and previously directed a drug information center at Mercer University College of Pharmacy.
TRTulasee Rao Chintha
Tulasee Rao ChinthaChief Technology Officer | Co-FounderTulasee Rao Chintha holds a Bachelor of Technology from Jawaharlal Nehru Technological University in India and brings over a decade of full-stack software development experience, including 10 years as an architect at Resource Logistics Inc and 5 years as a senior engineer at TCS, with expertise in artificial intelligence, cloud infrastructure, and IoT systems.

Investors · 13

Asymmetry Ventureslisted by Asymmetry VenturesRichmond · $125K – $500Kvia Rob Ness · inferred

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Atlanta Tech Villagelisted by Atlanta Tech VillageAtlanta
Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · startuprise.io · open dataset · 5k.vc investor directory · Not right? Tell us

AV Capitalreported

How we know: Y Combinator's founder network · Not right? Tell us

Blackwood Healthcare BreakthroughsreportedCoto De Caza

How we know: Y Combinator's founder network · Not right? Tell us

Engineering Leaders CommunityreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Hanmi Healthcarereported

How we know: Y Combinator's founder network · Not right? Tell us

Qlarant Commercial Solutionsreported

How we know: Y Combinator's founder network · Not right? Tell us

Share VenturesreportedPlaya Vista

How we know: Y Combinator's founder network · Not right? Tell us

Also in the syndicate · 3

Atlanta VenturesQlarant CapitalSF ELC

Funding

SEC filings, press & company announcements

$6M disclosed across 1 of 2 rounds · 2023

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 7

MDalgorithms Inc.MDalgorithms develops AI-powered personalized skincare and hair care solutions, including treatments for acne, hair regrowth, and anti-aging. The company uses machine learning models and proprietary image analysis technology to deliver customized treatment kits tailored to each user's specific skin and hair profile.
Quadrant EyeQuadrant Eye develops at-home diagnostic technology to conduct comprehensive eye examinations. The platform aims to increase access to eye care services and help prevent avoidable vision loss.
RTHMRTHM combines artificial intelligence with clinical expertise to help patients with complex and unexplained illnesses find faster paths to diagnosis and treatment. The platform serves patients and healthcare providers within the digital health and diagnostics industry.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Akute HealthAkute Health is an electronic health record (EHR) system designed for independent, cash-based clinical practices including direct primary care, med spas, and telehealth clinics. The platform offers task-based workflows, patient communication tools, and administrative automation to reduce overhead and enable providers to focus on patient care.
Ankr HealthAnkr provides patient care coordination and communication services that deliver clinical results same-day and enable direct doctor-patient communication outside standard clinic hours. The platform is designed for patients seeking streamlined healthcare interactions without repetitive form-filling.
OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.

Companies working in the same space as InpharmD.

Legal entities · 1

corporate structure
InpharmD, Inc.

In the news

Exclusive: InpharmD seeds $6M for on-demand drug infoinpharmd.com · Dec 2023InpharmD Funding | $2-5M Revenue | Complete Analysis | Extruct AIextruct.ai · Dec 2023InpharmD Raises $6.05M in Fundingfinsmes.com · Dec 2023Decoding InpharmD - Revolutionizing Drug Information with AIinpharmd.com · Dec 2023Qlarant Capital Becomes Investor in InpharmD™globenewswire.com · Jan 2023

Frequently asked questions

What does InpharmD do?
InPharmD is a medical literature research platform that analyzes published studies to answer clinical pharmacology questions, specifically focused on adverse drug reactions and medication safety.
Who founded InpharmD?
InpharmD was founded by Ashish Advani, Tulasee Rao Chintha in 2018.
Who are InpharmD's investors?
InpharmD's investors include 645 Ventures, Asymmetry Ventures, Atlanta Tech Village, Y Combinator, AV Capital, Blackwood Healthcare Breakthroughs, Engineering Leaders Community, Hanmi Healthcare and 2 more.
How much funding has InpharmD raised?
InpharmD has disclosed $6M raised across 1 of its 2 known rounds.
Where is InpharmD headquartered?
InpharmD is headquartered in Atlanta, US.